Immuno-virotherapy for glioblastoma: Characterization of Delta 24-ACT in combination with different immunomodulators as therapeutic approach

Immuno-virotherapy for glioblastoma: Characterization of Delta 24-ACT in combination with different immunomodulators as therapeutic approach

The tumor microenvironment of glioblastoma is extremely immunosuppressive due to high amount of myeloid cells leading to low levels of lymphocytes. This immunosuppressive scenario makes difficult the development of curative therapies for this devastating tumor. Our group has engineered Delta-24-ACT,...

Full description

Bibliographic Details
Main Authors: Puigdelloses-Vallcorba, M. (Montserrat), Alonso-Roldán, M.M. (Marta María), Gallego-Perez-Larraya, J. (Jaime)
Format: info:eu-repo/semantics/doctoralThesis
Language:eng
Published: Universidad de Navarra 2021
Subjects:
Materias Investigacion::Ciencias de la Salud::Oncología
Materias Investigacion::Ciencias de la Salud::Inmunología
Virus respiratorios
Online Access:https://hdl.handle.net/10171/61036

Internet

https://hdl.handle.net/10171/61036

Similar Items